Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.

For the first time, a device for releasing local chemotherapy in the bladder has been approved in the U.S., for patients who do not respond to standard treatment. The U.S. Food and Drug Administration ...